Table 2.

Use of asthma medication among responders with physician-diagnosed asthma.

	All responders with asthma	Responders reporting regular use of asthma medication	Responders reporting courses or as-needed use of asthma medication
Total	516*	446	70
ICS**	489 (94.8)	433 (97.1)	56 (80.0)
LABA**	286 (55.4)	264 (59.2)	22 (31.4)
LAMA**	41 (7.9)	41 (9.2)	0 (0.0)
LTRA	84 (16.3)	81 (18.2)	3 (4.3)
SABA/SAMA**	362 (70.2)	308 (69.1)	54 (77.1)

Data are presented as n (%). *Excluded 25 responders who had not specified the used asthma medication **Alone or fixed combination inhaler. ICS = inhaled corticosteroid. LABA = long-acting β2-agonist. LAMA = long-acting muscarinic antagonist. LTRA = leukotriene receptor antagonist. SABA = short-acting β2-agonist. SAMA = short-acting muscarinic antagonist. Note: triple combination inhalers (ICS+LABA+LAMA) were not available at the time of the study.